{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:14:48Z","timestamp":1715213688125},"reference-count":14,"publisher":"Kurume Medical Journal","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2019,12,31]]},"DOI":"10.2739\/kurumemedj.ms664001","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T22:08:04Z","timestamp":1632175684000},"page":"239-246","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial"],"prefix":"10.2739","volume":"66","author":[{"given":"AKIKO M","family":"SAITO","sequence":"first","affiliation":[{"name":"Laboratory of Clinical, Epidemiological and Health Services Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ISAO","family":"YOSHIDA","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIRO","family":"TANAKA","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MORIO","family":"SAWAMURA","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Shibukawa Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHIHIRO","family":"HIDAKA","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Kumamoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHIRO","family":"YOSHIDA","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagasaki Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOKUNI","family":"UIKE","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Kyushu Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIHIRO","family":"KANEKO","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Osaka City University Graduate School of Medicine"},{"name":"Research Center for Infectious Disease Sciences, Osaka City University Graduate School of Medicine"},{"name":"Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHITSUGU","family":"MIYAZAKI","sequence":"additional","affiliation":[{"name":"Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROKAZU","family":"NAGAI","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1445","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vartivarian SE, Anaissie EJ, and Bodey GP. Emerging Fungal Pathogens in Immunocompromised Patients: Classification, Diagnosis, and Management. Clin Infect Dis 1993; 17 Suppl 2:S487-S491.","DOI":"10.1093\/clinids\/17.Supplement_2.S487"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993; 17 Suppl 2:S481-S486.","DOI":"10.1093\/clinids\/17.Supplement_2.S481"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pannuti C, Gingrich R, Pfaller MA, Kao C, and Wenzel RP. Nosocomial Pneumonia in Patients Having Bone Marrow Transplant: Attributable Mortality and Risk Factors. Cancer 1992; 69:2653-2662.","DOI":"10.1002\/1097-0142(19920601)69:11<2653::AID-CNCR2820691106>3.0.CO;2-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marty FM, Cosimi LA, and Baden LR. Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants. N Engl J Med 2004; 350:950-952.","DOI":"10.1056\/NEJM200402263500923"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Siwek GT, Dodgson KJ, De Magalhaes-Silverman M, Bartelt LA, Kilborn SB et al. Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis. Clin Infect Dis 2004; 39:584-587.","DOI":"10.1086\/422723"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vigouroux S, Morin O, Moreau P, M\u00e9chinaud F, Morineau N et al. Zygomycosis after Prolonged Use of Voriconazole in Immunocompromised Patients with Hematologic Disease: Attention Required. Clin Infect Dis 2005; 40:e35-e37.","DOI":"10.1086\/427752"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Matsue K, Uryu H, Koseki M, Asada N, and Takeuchi M. Breakthrough Trichosporonosis in Patients with Hematologic Malignancies Receiving Micafungin. Clin Infect Dis 2006; 42:753-757.","DOI":"10.1086\/500323"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Goodman D, Pamer E, Jakubowski A, Morris C, and Sepkowitz K. Breakthrough Trichosporonosis in a Bone Marrow Transplant Recipient Receiving Caspofungin Acetate. Clin Infect Dis 2002; 35:e35-e36.","DOI":"10.1086\/341305"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito Y, Ohyashiki K, Yoshida I, Takeuchi M, Aoyama Y et al. The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Japanese Multicenter Randomized, Controlled Study. Int J Hematol 2007; 85:121-127.","DOI":"10.1532\/IJH97.06079"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC et al. Intravenous and Oral Itraconazole Versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy. A Randomized, Controlled Trial. Ann Intern Med 2001; 135:412-422.","DOI":"10.7326\/0003-4819-135-6-200109180-00010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008; 46:1813-1821.","DOI":"10.1086\/588660"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C et al. Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340:764-771.","DOI":"10.1056\/NEJM199903113401004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F et al. Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever. N Engl J Med 2002; 346:225-234.","DOI":"10.1056\/NEJM200201243460403"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR et al. Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia. N Engl J Med 2004; 351:1391-1402.","DOI":"10.1056\/NEJMoa040446"}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/4\/66_MS664001\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:15:34Z","timestamp":1715145334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/4\/66_MS664001\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms664001","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]},"article-number":"MS664001"}}